Gilead Sciences Stock Price on January 7, 2025
| GILD Stock | USD 90.63 0.60 0.66% |
Below is the normalized historical share price chart for Gilead Sciences extending back to January 22, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Gilead Sciences stands at 90.63, as last reported on the 8th of January, with the highest price reaching 91.51 and the lowest price hitting 90.51 during the day.
If you're considering investing in Gilead Stock, it is important to understand the factors that can impact its price. At this point, Gilead Sciences is very steady. Gilead Sciences holds Efficiency (Sharpe) Ratio of 0.0918, which attests that the entity had a 0.0918% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Gilead Sciences, which you can use to evaluate the volatility of the firm. Please check out Gilead Sciences' Downside Deviation of 1.55, risk adjusted performance of 0.0794, and Market Risk Adjusted Performance of 0.6975 to validate if the risk estimate we provide is consistent with the expected return of 0.14%.
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 75 B, whereas Capital Stock is forecasted to decline to about 901 K. . At present, Gilead Sciences' Price Book Value Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 11.93, whereas Price Earnings To Growth Ratio is forecasted to decline to 0.80. Gilead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of January 1992 | 200 Day MA 77.8085 | 50 Day MA 91.6148 | Beta 0.192 |
Gilead |
Sharpe Ratio = 0.0918
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | GILD | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.48 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Gilead Sciences is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding it to a well-diversified portfolio.
Price Book 6.1139 | Enterprise Value Ebitda 33.4765 | Price Sales 3.9913 | Shares Float 1.2 B | Dividend Share 3.06 |
Gilead Sciences Main Headline on 7th of January 2025
Poolbeg Pharma plc and HOOKIPA Pharma Inc. Update on Potenti... by finance.yahoo.com
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS . THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. For immediate release 7 January 2025
Gilead Sciences Valuation on January 7, 2025
It is possible to determine the worth of Gilead Sciences on a given historical date. On January 7, 2025 Gilead was worth 90.89 at the beginning of the trading date compared to the closed value of 90.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gilead Sciences stock. Still, in general, we apply an absolute valuation method to find Gilead Sciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gilead Sciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gilead Sciences' related companies.
| Open | High | Low | Close | Volume | |
| 90.75 | 91.53 | 90.33 | 91.23 | 6,756,354 | |
01/07/2025 | 90.89 | 91.51 | 90.51 | 90.63 | 5,661,344 |
| 90.89 | 91.51 | 90.51 | 90.63 | 0.00 |
| Backtest Gilead Sciences | | | Gilead Sciences History | | | Gilead Sciences Valuation | Previous | Next |
Gilead Sciences Trading Date Momentum on January 7, 2025
| On January 08 2025 Gilead Sciences was traded for 90.63 at the closing time. The top price for the day was 91.51 and the lowest listed price was 90.51 . There was no trading activity during the period 0.0. Lack of trading volume on January 8, 2025 did not cause price change. The overall trading delta against the current closing price is 0.29% . |
Gilead Sciences Fundamentals Correlations and Trends
By evaluating Gilead Sciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gilead Sciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gilead financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Gilead Sciences Stock history
Gilead Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gilead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gilead Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gilead Sciences stock prices may prove useful in developing a viable investing in Gilead Sciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.4 B | 1.5 B | |
| Net Income Applicable To Common Shares | 5.3 B | 4.9 B |
Gilead Sciences Quarterly Net Working Capital |
|
Gilead Sciences Stock Technical Analysis
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Gilead Sciences Period Price Range
Low | January 8, 2025
| High |
0.00 | 0.00 |
Gilead Sciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Gilead Sciences January 8, 2025 Market Strength
Market strength indicators help investors to evaluate how Gilead Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gilead Sciences shares will generate the highest return on investment. By undertsting and applying Gilead Sciences stock market strength indicators, traders can identify Gilead Sciences entry and exit signals to maximize returns
Gilead Sciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gilead Sciences' price direction in advance. Along with the technical and fundamental analysis of Gilead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gilead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0794 | |||
| Jensen Alpha | 0.1252 | |||
| Total Risk Alpha | 0.1261 | |||
| Sortino Ratio | 0.0813 | |||
| Treynor Ratio | 0.6875 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |